Iguana Healthcare Management Has Upped Its Boston Scientific (BSX) Holding by $2.03 Million; Share Value Rose; As Church & Dwight Com (CHD) Valuation Rose, Seizert Capital Partners Increased Its Holding

January 23, 2018 - By Winifred Garcia

Stuart Weisbrod increased its stake in Boston Scientific Corp (BSX) by 127.27% based on its latest 2017Q3 regulatory filing with the SEC. Iguana Healthcare Management Llc bought 70,000 shares as the company’s stock rose 4.02% with the market. The hedge fund run by Stuart Weisbrod held 125,000 shares of the medical and dental instruments company at the end of 2017Q3, valued at $3.65M, up from 55,000 at the end of the previous reported quarter. Iguana Healthcare Management Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $38.30 billion market cap company. The stock increased 0.66% or $0.1833 during the last trading session, reaching $27.8933. About 2.10 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since January 23, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Seizert Capital Partners Llc increased its stake in Church & Dwight Inc Com (CHD) by 5.19% based on its latest 2017Q3 regulatory filing with the SEC. Seizert Capital Partners Llc bought 45,454 shares as the company’s stock rose 0.08% with the market. The institutional investor held 921,588 shares of the basic industries company at the end of 2017Q3, valued at $44.65 million, up from 876,134 at the end of the previous reported quarter. Seizert Capital Partners Llc who had been investing in Church & Dwight Inc Com for a number of months, seems to be bullish on the $12.42B market cap company. The stock decreased 0.86% or $0.43 during the last trading session, reaching $49.68. About 739,057 shares traded. Church & Dwight Co., Inc. (NYSE:CHD) has risen 0.39% since January 23, 2017 and is uptrending. It has underperformed by 16.31% the S&P500.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It is positive, as 33 investors sold BSX shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. Endurant Cap LP owns 210,498 shares for 1.86% of their portfolio. Voya Inv Mgmt Limited Co holds 0.63% or 10.03 million shares. Suntrust Banks invested in 0% or 28,073 shares. Citadel Advsrs Ltd Company accumulated 0.05% or 2.08 million shares. The California-based Hanson Mcclain Incorporated has invested 0% in Boston Scientific Corporation (NYSE:BSX). Atalanta Sosnoff Capital Llc invested in 1.22 million shares or 1.23% of the stock. Advisor Partners Ltd Com holds 26,937 shares or 0.15% of its portfolio. Natixis holds 107,321 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt Sys holds 111,591 shares. 1832 Asset Mgmt Lp has 8,008 shares. Tiger Management Limited Com reported 1.07 million shares or 5.64% of all its holdings. Retirement System Of Alabama owns 0.19% invested in Boston Scientific Corporation (NYSE:BSX) for 1.27M shares. Reilly Financial Advsrs Llc has invested 0% in Boston Scientific Corporation (NYSE:BSX). Evercore Wealth Management Ltd Liability Corp reported 0.02% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Checchi Cap Advisers Limited Com stated it has 11,661 shares or 0.03% of all its holdings.

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 85 analyst reports since July 27, 2015 according to SRatingsIntel. RBC Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, June 9. RBC Capital Markets has “Outperform” rating and $31 target. As per Thursday, July 27, the company rating was maintained by BMO Capital Markets. The stock of Boston Scientific Corporation (NYSE:BSX) has “Buy” rating given on Thursday, July 27 by Cowen & Co. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Neutral” rating by BTIG Research on Monday, May 23. The company was maintained on Monday, September 25 by Stifel Nicolaus. Jefferies maintained it with “Hold” rating and $28.0 target in Tuesday, September 5 report. The stock of Boston Scientific Corporation (NYSE:BSX) has “Hold” rating given on Monday, June 26 by BTIG Research. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Needham on Friday, December 8. The stock of Boston Scientific Corporation (NYSE:BSX) has “Corporate” rating given on Thursday, October 29 by FinnCap. The stock has “Buy” rating by Needham on Thursday, October 26.

Since August 1, 2017, it had 0 insider purchases, and 13 selling transactions for $15.16 million activity. Pierce David A sold $139,104 worth of Boston Scientific Corporation (NYSE:BSX) on Tuesday, January 9. $208,328 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Sorenson John Bradley. Nanavaty Maulik had sold 57,031 shares worth $1.56 million. Carruthers Wendy also sold $332,584 worth of Boston Scientific Corporation (NYSE:BSX) on Thursday, August 3. $277,475 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Pratt Timothy A.. Bose Supratim sold 347,137 shares worth $10.11 million.

Iguana Healthcare Management Llc, which manages about $139.00M and $183.53M US Long portfolio, decreased its stake in Anaptysbio Inc by 20,000 shares to 50,000 shares, valued at $1.75 million in 2017Q3, according to the filing. It also reduced its holding in Zogenix Inc by 65,000 shares in the quarter, leaving it with 20,000 shares, and cut its stake in Lilly Eli & Co (NYSE:LLY).

Seizert Capital Partners Llc, which manages about $4.45B and $2.72B US Long portfolio, decreased its stake in Pfizer Inc Com (NYSE:PFE) by 51,300 shares to 432,000 shares, valued at $15.42 million in 2017Q3, according to the filing. It also reduced its holding in International Bancshares Corp (NASDAQ:IBOC) by 11,033 shares in the quarter, leaving it with 92,778 shares, and cut its stake in Old Second Bancorp Inc Ill Com (NASDAQ:OSBC).

Investors sentiment increased to 0.95 in Q3 2017. Its up 0.15, from 0.8 in 2017Q2. It increased, as 40 investors sold CHD shares while 228 reduced holdings. 66 funds opened positions while 189 raised stakes. 195.93 million shares or 0.21% less from 196.35 million shares in 2017Q2 were reported. Natl Planning holds 6,193 shares or 0.06% of its portfolio. Hyman Charles D holds 7,600 shares. Millennium Mgmt Limited Liability Co reported 93,049 shares. Sumitomo Life holds 27,421 shares or 0.17% of its portfolio. Bokf Na reported 23,159 shares. Principal Financial Group Inc Inc invested in 0.02% or 426,775 shares. Moreover, Lazard Asset Mgmt Ltd Limited Liability Company has 0% invested in Church & Dwight Co., Inc. (NYSE:CHD). Northwestern Mutual Wealth Mngmt invested in 0% or 4,901 shares. Moreover, Northwest Invest Counselors Ltd has 0.01% invested in Church & Dwight Co., Inc. (NYSE:CHD) for 450 shares. Wells Fargo Company Mn invested in 0.03% or 2.14 million shares. Fiduciary Trust holds 635,146 shares or 0.95% of its portfolio. Atria Invests holds 0.02% or 6,726 shares. Cibc Ww Markets Inc has invested 0.01% in Church & Dwight Co., Inc. (NYSE:CHD). Mai Cap Management holds 17,898 shares. State Treasurer State Of Michigan reported 0.03% stake.

Since August 7, 2017, it had 0 buys, and 3 insider sales for $10.00 million activity. $484,351 worth of Church & Dwight Co., Inc. (NYSE:CHD) was sold by LEBLANC ROBERT D on Wednesday, August 9. KATZ STEVEN J had sold 11,200 shares worth $561,896.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: